OncoVista Innovative Therapies, Inc.
OVIT · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Market Cap | $1,299 | $1,081 | $2,797 | $7,458 |
| - Cash | $13 | $45 | $512 | $2,125 |
| + Debt | $208 | $0 | $0 | $168 |
| Enterprise Value | $1,495 | $1,036 | $2,285 | $5,501 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,545 | -$1,519 | -$1,615 | -$2,199 |
| % Margin | – | – | – | – |
| Net Income | -$2,544 | -$1,450 | -$1,629 | -$2,025 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.07 | -0.08 | -0.1 |
| % Growth | -71.4% | 12.5% | 20% | – |
| Operating Cash Flow | -$232 | -$467 | -$1,554 | -$1,609 |
| Capital Expenditures | $0 | $0 | -$0 | -$3 |
| Free Cash Flow | -$232 | -$467 | -$1,554 | -$1,612 |